FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...